🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/02/1975 | 1,96 | 1,96 | 1,92 | 1,93 | -1,35% | 1,86% | 1.146.931 |
| 24/02/1975 | 1,97 | 1,97 | 1,93 | 1,96 | -0,84% | 2,02% | 1.784.534 |
| 21/02/1975 | 1,96 | 1,99 | 1,96 | 1,98 | +1,53% | 1,69% | 1.407.254 |
| 20/02/1975 | 1,93 | 1,95 | 1,90 | 1,95 | +0,69% | 2,57% | 1.475.165 |
| 19/02/1975 | 1,93 | 1,94 | 1,88 | 1,93 | +0,34% | 3,43% | 2.203.315 |
| 18/02/1975 | 1,97 | 1,97 | 1,92 | 1,93 | -2,18% | 2,35% | 1.622.304 |
| 14/02/1975 | 1,93 | 1,98 | 1,93 | 1,97 | +1,88% | 2,74% | 1.852.445 |
| 13/02/1975 | 1,93 | 1,99 | 1,93 | 1,93 | +0,87% | 2,74% | 4.640.544 |
| 12/02/1975 | 1,86 | 1,92 | 1,85 | 1,92 | +3,39% | 3,75% | 2.297.635 |
| 11/02/1975 | 1,86 | 1,89 | 1,85 | 1,86 | -0,35% | 2,13% | 1.433.664 |
| 10/02/1975 | 1,86 | 1,88 | 1,84 | 1,86 | +0,00% | 1,78% | 1.705.306 |
| 07/02/1975 | 1,84 | 1,87 | 1,81 | 1,86 | +1,26% | 3,06% | 1.320.480 |
| 06/02/1975 | 1,85 | 1,89 | 1,82 | 1,84 | -0,36% | 3,95% | 3.572.842 |
| 05/02/1975 | 1,77 | 1,85 | 1,76 | 1,85 | +4,31% | 4,68% | 2.358.000 |
| 04/02/1975 | 1,72 | 1,80 | 1,70 | 1,77 | +3,09% | 5,40% | 2.075.040 |
| 03/02/1975 | 1,69 | 1,72 | 1,69 | 1,72 | +1,97% | 1,57% | 1.893.946 |
| 31/01/1975 | 1,69 | 1,70 | 1,66 | 1,68 | -0,58% | 1,96% | 3.448.339 |
| 30/01/1975 | 1,74 | 1,79 | 1,69 | 1,69 | -2,85% | 5,70% | 3.048.422 |
| 29/01/1975 | 1,69 | 1,75 | 1,68 | 1,74 | +3,34% | 3,93% | 2.263.680 |
| 28/01/1975 | 1,71 | 1,74 | 1,68 | 1,69 | -1,17% | 3,49% | 3.372.883 |
| 27/01/1975 | 1,67 | 1,71 | 1,67 | 1,71 | +3,41% | 1,98% | 3.331.382 |
| 24/01/1975 | 1,63 | 1,65 | 1,63 | 1,65 | +1,43% | 1,63% | 1.731.715 |
| 23/01/1975 | 1,63 | 1,66 | 1,61 | 1,63 | +0,00% | 3,06% | 1.180.886 |
| 22/01/1975 | 1,56 | 1,63 | 1,55 | 1,63 | +4,25% | 5,09% | 2.652.278 |
| 21/01/1975 | 1,56 | 1,58 | 1,55 | 1,56 | +0,21% | 1,91% | 2.256.134 |
| 20/01/1975 | 1,56 | 1,58 | 1,52 | 1,56 | -0,21% | 3,40% | 3.105.014 |
| 17/01/1975 | 1,63 | 1,63 | 1,56 | 1,56 | -4,27% | 4,67% | 3.048.422 |
| 16/01/1975 | 1,64 | 1,67 | 1,63 | 1,63 | -0,40% | 2,43% | 1.927.901 |
| 15/01/1975 | 1,63 | 1,64 | 1,57 | 1,64 | +0,40% | 4,26% | 2.969.194 |
| 14/01/1975 | 1,66 | 1,66 | 1,62 | 1,63 | -2,18% | 2,39% | 1.656.259 |